More than 800 million individuals have diabetes globally, doubling in the last three decades according to research recently ...

This immune response results in chronic high blood sugar for diabetes patients, which can lead to other serious health ...

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering ...

Type 1 diabetes, once known as juvenile or insulin-dependent diabetes, is a chronic health condition. In people with this affliction, the pancreas makes little or no insulin, the hormone the body uses ...

China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting "good momentum" for its already-approved Victoza, and its successor semaglutide.

In a surprising twist that challenges conventional wisdom about body weight and health, new research suggests that having a ...

Adult non–insulin requiring diabetes includes latent autoimmune diabetes of adults (LADA), distinguished from type 2 diabetes by the presence of islet autoantibodies. LADA China determined the ...

Corxel Pharmaceuticals (CORXEL), a leading biotech company committed to bringing innovative science and medicines to underserved patients with cardiometabolic diseases around the world, today ...

Revenue in the Diabetes Care Devices market market in China is anticipated to reach US$3.40bn in 2024. This revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 13.52% ...

A new round of China's bulk buy program for drugs will include 385 products from 234 companies in an effort to further reduce ...

Moderate- to vigorous-intensity physical activity (MVPA) during pregnancy is inversely associated with preterm birth in women ...